These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1905348)

  • 1. Low-dose interferon gamma renders neuroblastoma more susceptible to interleukin-2 immunotherapy.
    Sigal RK; Lieberman MD; Reynolds JV; Shou J; Ziegler MM; Daly JM
    J Pediatr Surg; 1991 Apr; 26(4):389-95; discussion 395-6. PubMed ID: 1905348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of interleukin-2 immunotherapy with L-arginine.
    Lieberman MD; Nishioka K; Redmond HP; Daly JM
    Ann Surg; 1992 Feb; 215(2):157-65. PubMed ID: 1546902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined preoperative and postoperative immunotherapy for murine C1300 neuroblastoma.
    Fowler CL; Brooks SP; Rossman JE; Cooney DR
    J Pediatr Surg; 1993 Mar; 28(3):420-6; discussion 426-7. PubMed ID: 8468657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of mouse melanoma by combined treatment with recombinant human interleukin 2 and recombinant murine interferon-gamma.
    Silagi S; Dutkowski R; Schaefer A
    Int J Cancer; 1988 Feb; 41(2):315-22. PubMed ID: 3123404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy.
    Neal ZC; Imboden M; Rakhmilevich AL; Kim KM; Hank JA; Surfus J; Dixon JR; Lode HN; Reisfeld RA; Gillies SD; Sondel PM
    Cancer Immunol Immunother; 2004 Jan; 53(1):41-52. PubMed ID: 14504825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of natural killer cells in neuroblastoma.
    Reynolds JV; Shou J; Choi H; Sigal R; Ziegler MM; Daly JM
    Arch Surg; 1989 Feb; 124(2):235-9. PubMed ID: 2492800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma.
    Aiken TJ; Erbe AK; Zebertavage L; Komjathy D; Feils AS; Rodriguez M; Stuckwisch A; Gillies SD; Morris ZS; Birstler J; Rakhmilevich AL; Sondel PM
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells.
    Naganuma H; Kiessling R; Patarroyo M; Hansson M; Handgretinger R; Grönberg A
    Int J Cancer; 1991 Feb; 47(4):527-32. PubMed ID: 1671670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo.
    Redlinger RE; Mailliard RB; Lotze MT; Barksdale EM
    J Pediatr Surg; 2003 Mar; 38(3):301-7; discussion 301-7. PubMed ID: 12632339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose natural interleukin-2 and recombinant interferon-gamma following autologous bone marrow grafts in pediatric patients with high-risk acute leukemia.
    Baumgarten E; Schmid H; Pohl U; Brzoska J; Linderkamp C; Siegert W; Henze G
    Leukemia; 1994 May; 8(5):850-5. PubMed ID: 8182941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cells.
    Handgretinger R; Kimmig A; Lang P; Daurer B; Kuci S; Bruchelt G; Treuner J; Niethammer D
    Nat Immun Cell Growth Regul; 1989; 8(4):189-96. PubMed ID: 2507905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of interferons in neuroblastoma. 2: Immunomodulatory effects].
    Handgretinger R; Bruchelt G; Daurer B; Lang P; Dopfer R; Reisfeld RA; Treuner J; Niethammer D
    Klin Padiatr; 1990; 202(4):206-11. PubMed ID: 2118581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
    Papa MZ; Mulé JJ; Rosenberg SA
    Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect inhibition of generation of murine lymphokine-activated killer cell activity in splenocyte cultures by interferon-gamma.
    Chao TY; Ohnishi H; Chu TM
    Immunology; 1990 May; 70(1):116-20. PubMed ID: 2113034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of interferon-gamma in the immunotherapy of neuroblastoma.
    Handgretinger R; Bruchelt G; Daurer B; Lang P; Herter M; Dopfer R; Müller B; Reisfeld RA; Treuner J; Niethammer D
    Prog Clin Biol Res; 1991; 366():401-7. PubMed ID: 1906184
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune-mediated regression of 'metastatic' neuroblastoma in the liver.
    Ishizu H; Bove KE; Ziegler MM; Arya G
    J Pediatr Surg; 1994 Feb; 29(2):155-9; discussion 159-60. PubMed ID: 8176585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced resection and improved survival in murine neuroblastoma (C1300-NB) after preoperative immunotherapy.
    Fowler CL; Brooks SP; Squire R; Rich GA; Rossman JE; Finegold MJ; Allen JE; Cooney DR
    J Pediatr Surg; 1991 Apr; 26(4):381-7; discussion 387-8. PubMed ID: 2056397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A novel experimental approach to immunotherapy against malignant brain tumor with the mouse IFN-gamma gene transfer].
    Nishihara K
    Nihon Geka Hokan; 1989 Jan; 58(1):18-42. PubMed ID: 2508589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative immunotherapy of murine C1300-neuroblastoma.
    Fowler CL; Brooks SP; Rossman JE; Cooney DR
    J Pediatr Surg; 1990 Feb; 25(2):229-37. PubMed ID: 1689384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.